OcuPair, a Novel Photo‐crosslinkable PAMAM Dendrimer‐Hyaluronic Acid Hydrogel Bandage/Bioadhesive for Corneal Injuries and Temporary Corneal Repair
Traumatic corneal injuries are a leading cause of blindness among military personnel. These injuries need immediate attention in the combat zone, but treatment options are limited as life-saving measures are often prioritized. To address this critical gap, we have developed OcuPair<sup>TM</sup>, a two-component hydrogel system that consists of i) an injectable viscoelastic filler that stabilizes the ocular cavity and prevents hypotony. ii) An in situ photo-curable adhesive hydrogel comprising of methacrylated, hydroxyl PAMAM dendrimer and hyaluronic acid engineered to form a transparent, flexible, and robust bandage within 90 seconds, adhering to the corneal surface and ensuring a water-tight seal securing full-thickness corneal wounds. Ex vivo studies demonstrated that the adhesive hydrogel is mechanically robust and withstands intraocular pressures beyond physiological range. In a rabbit corneal injury model, OcuPair<sup>TM</sup> effectively sealed complex full-thickness wounds and preserved the eye with favorable clinical outcomes for 5 days with no toxicity over 30 days. In this study, we have validated the pilot scale synthesis, formulation optimization, GMP scale-up, and IDE-enabling GLP toxicity, essential for clinical translation as a battlefield-ready solution.
Authors
- Rangaramanujam M. Kannan (ORCID: https://orcid.org/0000-0002-3712-7836)
- Rishi Sharma (ORCID: https://orcid.org/0000-0002-7069-7099)
- Hui Lin (ORCID: https://orcid.org/0000-0003-4003-5972)
- Jeffrey L. Cleland (ORCID: https://orcid.org/0000-0002-5867-7589)
- Santiago Appiani
- Siva P. Kambhampati
- Samuel C. Yiu
Institutions
- Johns Hopkins University (US)
- Johns Hopkins Medicine (US)
- Abeona Therapeutics (United States) (US)
Publication Details
- Journal
- Advanced Science
- Published
- 2025-03-27
- DOI
- https://doi.org/10.1002/advs.202417731
- Citations
- 6
- Primary Topic
- Corneal Surgery and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 8.16
Funders
- Foundation Fighting Blindness